LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Hungarian Biotechnology Association joins EuropaBio: Strengthening Hungary’s Biotech Voice in Europe

28/11/2025

PRESS RELEASE

Brussels, 28 November 2025 – EuropaBio is proud to welcome its newest member, the Hungarian Biotechnology Association (Magyar Biotechnológiai Szövetség), into its growing network of national and regional biotech organisations.

Founded in 2003, the Hungarian Biotechnology Association serves as the national platform representing Hungary’s dynamic biotechnology ecosystem. Its membership spans startups, SMEs and large biotech and pharmaceutical companies. The Association’s mission is to promote innovation, foster collaboration between industry and academia, and support policy development that enhances Hungary’s role in the European biotech landscape.

By joining EuropaBio, the Association aims to connect its members with the broader European biotech community, facilitate cross-border partnerships, and ensure that Hungary’s biotech innovations are visible and influential at the EU level. The organisation is committed to contributing to EU policy discussions and strengthening advocacy for Hungarian biotech companies and research institutions.

Dr Claire Skentelbery, Director General of EuropaBio, commented: “EuropaBio’s National Associations Council continues to strengthen its voice with the welcome addition of the Hungarian Biotechnology Association. Hungary brings significant biotechnology capacity and we are delighted to bring the team into our work.”

Zita Sepsi, Co-Managing Director of the Hungarian Biotechnology Association, said: “Joining EuropaBio is an important milestone for the Hungarian Biotechnology Association in its renewal. We are committed to strengthening Hungary’s presence within the European biotech community and look forward to building partnerships that support our members in innovating, growing, and contributing to Europe’s competitiveness. We value the opportunity to work together on shared challenges and to actively engage with colleagues across Europe.”

For more information, please visit hungarianbiotech.org

Hungarian Biotechnology Association joins EuropaBio: Strengthening Hungary’s Biotech Voice in Europe


Download
Share
Adrian Lincoln
Adrian Lincoln

Related posts

28/11/2025

Bioeconomy strategy sets the right pathway for Europe


Read more
14/11/2025

Vial joins EuropaBio: Reimagining Drug Development with Hyper-Scalable Biotech


Read more
12/11/2025

EuropaBio response to the EU Biotech Act public consultation


Read more

Important links

  • Bioeconomy strategy sets the right pathway for Europe
  • Hungarian Biotechnology Association joins EuropaBio: Strengthening Hungary’s Biotech Voice in Europe

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.